go back

New Mexico rates for HCPCS Q2053

Brexucabtagene autoleucel, up to 200 million autologous anti-CD19 CAR positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $537,032 · 10th–90th $489,779–$1,412,5380%50%10th90th$537,032Professionalmedian $489,779 · 10th–90th $489,779–$575,4400%50%90th$489,779$0.1$1.0$20.0$500.0$10.0K$200.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$537,031.80 / $758,577.58 / $1,412,537.54
Aetna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$489,778.82 / $489,778.82 / $562,341.33
Molina
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$489,778.82 / $489,778.82 / $1,047,128.55
Providence
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$489,778.82 / $537,031.80 / $812,830.52
Providence
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$588,843.66 / $616,595.00 / $758,577.58
United
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$489,778.82 / $489,778.82 / $812,830.52
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$489,778.82 / $489,778.82 / $512,861.38